Histogen Inc. (CNAT) [Rocket]

Overview

Histogen Inc. (CNAT)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/12/2023	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/04/2023	PRE 14A	Form PRE 14A - Other preliminary proxy statements:
10/03/2023	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement  Interactive Data
09/26/2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2023	8-K	Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
08/10/2023	10-Q	Quarterly Report for the period ended June 30, 2023
07/05/2023	8-K	Other Events, Financial Statements and Exhibits  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
Revenues	3.8	3.8	1.0	1.0	2.1	11.5	33.6	35.4
Revenue growth	265.2%	265.2%	-49.9%		-82.0%	-65.9%	-5.1%	4327.7%
Cost of goods sold	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.0
Gross profit	3.8	-1.3	1.0	0.8	2.1	11.5	33.6	35.4
Gross margin	100.0%	-33.2%	100.0%	78.7%	100.0%	100.0%	100.0%	100.0%
Selling, general and administrative	14.4		16.5
Research and development					6.2	4.1	41.4	43.2
General and administrative		9.4		7.8	6.6	6.2	10.5	9.7
EBIT	-10.6	-10.6	-15.5	-15.5	-11.7	-1.1	-18.3	-17.6
EBIT margin	-282.4%	-282.4%	-1497.8%	-1497.8%	-568.9%	-9.3%	-54.4%	-49.6%
Pre-tax income	0.0	-10.6	0.0	-15.0	-18.8	-3.0	-18.0	-17.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate		0.0%		0.0%	0.0%	0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	0.0	-18.8	-3.0	-18.0	-17.4
Net margin	0.0%	-0.3%	0.0%	-1.4%	-911.6%	-25.9%	-53.6%	-49.2%

Diluted EPS	$0.00	($3.46)	$0.00	($7.79)	($2.08)	($0.89)	($0.59)	($0.61)
Shares outstanding (diluted)	3.2	0.0	1.9	0.0	9.0	3.3	30.4	28.6

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.